INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
INVO Bioscience Inc (INVO) - Total Assets
Latest total assets as of September 2024: $17.02 Million USD
Based on the latest financial reports, INVO Bioscience Inc (INVO) holds total assets worth $17.02 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
INVO Bioscience Inc - Total Assets Trend (2006–2023)
This chart illustrates how INVO Bioscience Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
INVO Bioscience Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
INVO Bioscience Inc's total assets of $17.02 Million consist of 6.0% current assets and 94.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.1% |
| Accounts Receivable | $140.55K | 0.7% |
| Inventory | $264.51K | 1.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.09 Million | 19.6% |
| Goodwill | $5.88 Million | 28.2% |
Asset Composition Trend (2006–2023)
This chart illustrates how INVO Bioscience Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INVO Bioscience Inc's current assets represent 6.0% of total assets in 2023, a decrease from 36.5% in 2006.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2023, down from 36.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 28.2% of total assets.
INVO Bioscience Inc Competitors by Total Assets
Key competitors of INVO Bioscience Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
INVO Bioscience Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - INVO Bioscience Inc generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - INVO Bioscience Inc is currently not profitable relative to its asset base.
INVO Bioscience Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.23 | 0.37 | 1.03 |
| Quick Ratio | 0.20 | 0.31 | 0.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.70 Million | $ -3.09 Million | $ 42.33K |
INVO Bioscience Inc - Advanced Valuation Insights
This section examines the relationship between INVO Bioscience Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.97 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 409.0% |
| Total Assets | $20.89 Million |
| Market Capitalization | $2.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values INVO Bioscience Inc's assets below their book value (0.14 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INVO Bioscience Inc's assets grew by 409.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INVO Bioscience Inc (2006–2023)
The table below shows the annual total assets of INVO Bioscience Inc from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $20.89 Million | +409.00% |
| 2022-12-31 | $4.10 Million | -60.79% |
| 2021-12-31 | $10.47 Million | -4.39% |
| 2020-12-31 | $10.95 Million | +509.72% |
| 2019-12-31 | $1.80 Million | +130.98% |
| 2018-12-31 | $777.35K | +191.78% |
| 2017-12-31 | $266.41K | -54.05% |
| 2016-12-31 | $579.79K | 0.00% |
| 2015-12-31 | $579.79K | +436.59% |
| 2014-12-31 | $108.05K | -11.83% |
| 2013-12-31 | $122.54K | -2.18% |
| 2012-12-31 | $125.27K | -2.04% |
| 2011-12-31 | $127.88K | -29.35% |
| 2010-12-31 | $181.00K | -37.12% |
| 2009-12-31 | $287.84K | -7.61% |
| 2008-12-31 | $311.56K | +939.14% |
| 2007-12-31 | $29.98K | -20.66% |
| 2006-12-31 | $37.79K | -- |